Beat HIV

Menu

 

Latest Study

Abdel-Mohsen M, Kuri-Cervantes L, Montaner LJ, et al. “CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells.” Sci Transl Med. 2018 Apri 18;10 (437) pii: eaar6759. doi: 10.1126/scitranslmed.aar6759.

 

Szaniawski, M.A., Spivak, A.M., Cox, J.E., Catrow, J.L., Hanley, T., Williams, ESCP., Tremblay, M.J., Bosque, A., Planelles, V. “SAMHD1 Phosphorylation Coordinates the Anti-HIV-1 Response by Diverse Interferons and Tyrosine Kinase Inhibition.” MBio. 2018 May 15;9(3). pii: e00819-18. doi: 10.1128/mBio.00819-18.

 

Ecker C, Guo L, Voicu S, Gil-de-Gomez L, Medvec A, Cortina L, Pajda J, Andolina M, Torres-Castillo M, Donato JL, Mansour S, Zynda ER, Lin PY, Varela-Rohena A, Blair IA, Riley JL. “Differential Reliance on Lipid Metabolism as a Salvage Pathway Underlies Functional Differences of T Cell Subsets in Poor Nutrient Environments.” Cell Rep. 2018 Apr 17;23(3):741-755. doi: 10.1016/j.celrep.2018.03.084.

 

Vadrevu SK, Trbojevic-Akmacic I, Kossenkov AV, Colomb F, Giron LB, Anzurez A, Lynn K, Mounzer K, Landay AL, Kaplan RC, Papasavvas E, Montaner LJ, Lauc G, Abdel-Mohsen M. “Frontline Science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy.” J Leukoc Biol. 2018 Apr 6. doi: 10.1002/JLB.3HI1217-500R. [Epub ahead of print]

 

Cohen YZ, Lorenzi JCC, Seaman MS, Nogueira L, Schoofs T, Krassnig L, Butler A, Millard K, Fitzsimons T, Daniell X, Dizon JP, Shimeliovich I, Montefiori DC, Caskey M, Nussenzweig MC. “Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells.” J Virol. 2018 Feb 12;92(5). pii: e01883-17. doi: 10.1128/JVI.01883-17. Print 2018 Mar 1.

 

Cummins NW, Rizza S, Litzow MR, Hua S, Lee GQ, Einkauf K, Chun TW, Rhame F, Baker JV, Busch MP, Chomont N, Dean PG, Fromentin R, Haase AT, Hampton D, Keating SM, Lada SM, Lee TH, Natesampillai S, Richman DD, Schacker TW, Wietgrefe S, Yu XG, Yao JD, Zeuli J, Lichterfeld M, Badley AD. “Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.” PLoS Med. 2017 Nov 28;14(11):e1002461. doi: 10.1371/journal.pmed.1002461. eCollection 2017 Nov.

 

Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A, Kearney MF, Anderson EM, Buchbinder SP, Cohen SE, Abdel-Mohsen M, Pohlmeyer CW, Fromentin R, Hoh R, Liu AY, McCune JM, Spindler J, Metcalf-Pate K, Hobbs KS, Thanh C, Gibson EA, Kuritzkes DR, Siliciano RF, Price RW, Richman DD, Chomont N, Siliciano JD, Mellors JW, Yukl SA, Blankson JN, Liegler T, Deeks SG. “HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.” PLoS Med. 2017 Nov 7;14(11):e1002417. doi: 10.1371/journal.pmed.1002417. eCollection 2017 Nov.

 

Spivak AM, Planelles V. “Novel Latency Reversal Agents for HIV-1 Cure.” Annu Rev Med. 2017 Nov 3. [Epub ahead of print.]

 

Leibman RS, Richardson MW, Ellebrecht CT, Maldini CR, Glover JA, Secreto AJ, et al. “Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor.” PLoS Pathog. 2017;13(10): e1006613.

 

Mikulak J, Oriolo F, Zaghi E, Di Vito C, Mavilio D.” Natural Killer Cells in HIV-1 Infection and Therapy.” AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001645.

 

Kurachi M, Kurachi J, Chen Z, Johnson J, Khan O, Bengsch B, Stelekati E, Attanasio J, McLane LM, Tomura M, Ueha S, Wherry EJ. “Optimized retroviral transduction of mouse T cells for in vivo assessment of gene function.” Nat Protoc. 2017 Sep;12(9):1980-1998. doi: 10.1038/nprot.2017.083. Epub 2017 Aug 31.

 

Yek C, Massanella M, Peling T, Lednovich K, Nair SV, Worlock A, Vargas M, Gianella S, Ellis RJ, Strain MC, Busch MP, Nugent T, Richman DC. “Evaluation of the Aptima HIV-1 Quant Dx Assay for HIV-1 RNA Quantitation in Different Biological Specimen Types.” J Clin Microbiol. 2017 August;55(8):2544-2553. doi: 10.1128/JCM.00425-17.

 

Honeycutt JB, Thayer WO, Baker CE, Ribeiro RM, Lada SM, Cao Y, Cleary RA, Hudgens MG, Richman DD, Garcia JV. “HIV Persistence in tissue macrophages of humanized mice during ART.” Nat Med. 2017 May;23(5):638-643. doi: 10.1038/nm.4319.

 

Pollack RA, Jones RB, Pertea M, Bruner KM, Martin AR, Thomas AS, Capoferri AA, Beg SA, Huang SH, Karandish S, Hao H, Halper-Stromberg E, Yong PC, Kovacs C, Benko E, Siliciano RF, Ho YC. “Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape.Cell Host Microbe. 2017 Apr 12;21(4):494-506.e4. doi: 10.1016/j.chom.2017.03.008.

 

Hosmane NN, Kwon KJ, Bruner KM, Capoferri AA, Beg S, Rosenbloom DI, Keele BF, Ho YC, Siliciano JD, Siliciano RF. “Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics.” J Exp Med. 2017 Mar 24. pii: jem.20170193. doi: 10.1084/jem.20170193.

 

Mikulak J, Di Vito C, Zaghi E, Mavilio D. “Host Immune Responses in HIV-1 Infection: The Emerging Pathogenic Role of Siglecs and Their Clinical Correlates.” Front Immunol. 2017 Mar 23;8:314. doi: 10.3389/fimmu.2017.00314.

 

Riley JL, Montaner LJ. “Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir.” J Infect Dis. 2017 Mar 15;215(suppl_3):S160-S171. doi: 10.1093/infdis/jix002.

 

Martin AR, Pollack RA, Capoferri A, Ambinder RF, Durand CM, Siliciano RF. “Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity.” J Clin Invest. 2017 Feb 1;127(2):651-656. doi: 10.1172/JCI89552. PMID: 28094770

 

Tomescu C, Tebas P, Montaner. “IFN-α Augments NK-mediated Antibody-Dependent Cellular Cytotoxicity (ADCC) of HIV-1 Infected Autologous CD4+ T Cells Regardless of MHC-I Downregulation.” AIDS.  2017 Jan.  DOI: 10.1097/QAD.0000000000001380

 

Caskey M, Schoofs T, Gruell H, Settler A, Karagounis T, Kreider EF, Murrell B, Pfeifer N, Nogueira L, Oliveira TY, Learn GH, Cohen YZ, Lehmann C, Gillor D, Shimeliovich I, Unson-O’Brien C, Weiland D, Robles A, Kümmerle T, Wyen C, Levin R, Witmer-Pack M, Eren K, Ignacio C, Kiss S, West AP Jr, Mouquet H, Zingman BS, Gulick RM, Keler T, Bjorkman PJ, Seaman MS, Hahn BH, Fätkenheuer G, Schlesinger SJ, Nussenzweig MC, Klein F. “Antibody 10-1074 suppresses viremia in HIV-1 infected individuals.” Nat Med. 2017 Jan 16. doi: 10.1038/nm.4268. [Epub ahead of print] PMID: 28092665 [PubMed – as supplied by publisher]

 

Iyer SS, Bibollet-Ruche F, Sherrill-Mix S, Learn GH, Plenderleith L, Smith AG, Barbian HJ, Russell RM, Gondim MV, Bahari CY, Shaw CM, Li Y, Decker T, Haynes BF, Shaw GM, Sharp PM, Borrow P, Hahn BH. “Resistance to type I interferons is a major determinant of HIV-1 transmission fitness.” Proc Natl Acad Sci U S A. 2017 Jan 24;114(4): E590-E599. doi: 10.1073/pnas.1620144114. PMID: 28069935 [PubMed – in process]

 

Yuan Z, Kang G, Lu W, and Li Q. “Reactivation of HIV-1 proviruses in immune-compromised mice engrafted with human VOA-negative CD4+ T Cells.” J Virus Eradication. 2017; 3: 61-65.

 

Lorenzi JC, Cohen YZ, Cohn LB, Kreider EF, Barton JP, Learn GH, Oliveira T, Lavine CL, Horwitz JA, Settler A, Jankovic M, Seaman MS, Chakraborty AK, Hahn BH, Caskey M, Nussenzweig MC. “Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.” Proc Natl Acad Sci U S A. 2016 Dec 6;113(49): E7908-E7916. Erratum in: Proc Natl Acad Sci U S A. 2017 Jan 17.  PMID: 27872306 [PubMed – in process]

 

Bar KJ, Sneller MC, Harrison LJ, Justement JS, Overton ET, Petrone ME, Salantes DB, Seamon CA, Scheinfeld B, Kwan RW, Learn GH, Proschan MA, Kreider EF, Blazkova J, Bardsley M, Refsland EW, Messer M, Clarridge KE, Tustin NB, Madden PJ, Oden K, O’Dell SJ, Jarocki B, Shiakolas AR, Tressler RL, Doria-Rose NA, Bailer RT, Ledgerwood JE, Capparelli EV, Lynch RM, Graham BS, Moir S, Koup RA, Mascola JR, Hoxie JA, Fauci AS, Tebas P, Chun TW. “Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption.” N Engl J Med. 2016 Nov 24;375(21):2037-2050. PMID: 27959728 [PubMed – indexed for MEDLINE]